Serum FGF21 increases with hepatic fat accumulation in pediatric onset intestinal failure

Journal of Hepatology

Volumn 60, Issue 1, 2014, Pages 183-190

  Mutanen, Annika ^a   Heikkilä, Päivi ^b   Lohi, Jouko ^b   Raivio, Taneli ^c   Jalanko, Hannu ^a   Pakarinen, Mikko P ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c BIOMEDICUM HELSINKI   (Finland)

Author keywords

Children; Glucose homeostasis; Intestinal failure; Liver steatosis; Serum lipids

Indexed keywords

FIBROBLAST GROWTH FACTOR 21; LIPID EMULSION; ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BILIRUBIN GLUCURONIDE; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PREALBUMIN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGANGLIONOSIS; ARTICLE; CHILD; CHILDHOOD DISEASE; CHOLESTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FATTY LIVER; FEMALE; HIRSCHSPRUNG DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINAL DYSMOTILITY; INTESTINAL FAILURE; INTESTINE ATRESIA; INTESTINE PARAMETERS; INTESTINE PSEUDOOBSTRUCTION; INTESTINE VOLVULUS; LIPID STORAGE; LIVER BIOPSY; LIVER FIBROSIS; MALE; MALLORY BODY; NECROTIZING ENTEROCOLITIS; ONSET AGE; PARENTERAL NUTRITION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SHORT BOWEL SYNDROME; SMALL INTESTINE; WEANING; ASSOCIATION; BLOOD SAMPLING; CROSS-SECTIONAL STUDY; INFANT; INTESTINE RESECTION; LIVER HISTOLOGY; TREATMENT DURATION;

ALANINE AMINOTRANSFERASE; ALT; APRI; ASPARTATE AMINOTRANSFERASE; AST; AST-TO-PLATELET RATIO INDEX; BMI; BODY MASS INDEX; BODY MASS INDEX-FOR-AGE; CHILDREN; FGF21; FIBROBLAST GROWTH FACTOR 21; GLUCOSE HOMEOSTASIS; GLUTAMYL TRANSFERASE; GLYCOSYLATED HEMOGLOBIN; GT; HBA1C; HDL; HIGH-DENSITY LIPOPROTEIN; HOMA-IR; HOMEOSTASIS MODEL ASSESSMENT; IF; IFALD; INR; INTERNATIONAL NORMALIZED RATIO; INTESTINAL FAILURE; INTESTINAL FAILURE ASSOCIATED LIVER DISEASE; ISO-BMI; LDL; LIVER STEATOSIS; LOW-DENSITY LIPOPROTEIN; NASH; NONALCOHOLIC STEATOHEPATITIS; P-TT; PARENTERAL NUTRITION; PLASMA TROMBOPLASTIN TIME; PN; SERUM LIPIDS;

ABDOMEN; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; FIBROBLAST GROWTH FACTORS; GASTROINTESTINAL MOTILITY; HUMANS; INFANT; INTESTINAL DISEASES; LIVER; MALE; PARENTERAL NUTRITION; SHORT BOWEL SYNDROME;

EID: 84890565195     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.09.003     Document Type: Article

References (50)

1. O. Goulet, F. Ruemelle, F. Lacaille, and V. Colomb Irreversible intestinal failure J Pediatr Gastroenterol Nutr 38 2004 250 269
2. B.A. Carter, and S.J. Karpen Intestinal failure-associated liver disease: management and treatment strategies past, present, and future Semin Liver Dis 27 2007 251 258
3. D.A. Kelly Intestinal failure-associated liver disease: what do we know today? Gastroenterology 130 2006 S70 S77
4. L. D'Antiga, and O. Goulet Intestinal failure in children: the European view J Pediatr Gastroenterol Nutr 56 2013 118 126
5. L. Pironi, O. Goulet, A. Buchman, B. Messing, S. Gabe, and M. Candusso Outcome on home parenteral nutrition for benign intestinal failure: a review of the literature and benchmarking with European prospective survey of ESPEN Clin Nutr 31 2012 831 845
6. A. Mutanen, J. Lohi, P. Heikkilä, A.I. Koivusalo, R.J. Rintala, and M.P. Pakarinen Persistent abnormal liver fibrosis after weaning off parenteral nutrition in pediatric intestinal failure Hepatology 2013 10.1002/hep.26360 [Epub ahead of print]
7. D.F. Mercer, B.D. Hobson, R.T. Fischer, G.A. Talmon, D.A. Perry, and B.K. Gerhardt Hepatic fibrosis persists and progress despite biochemical improvement in children treated with intravenous fish oil emulsions J Pediatr Gastroenterol Nutr 56 2013 364 369
8. S.V. Beath, P. Davies, A. Papadopoulou, A.R. Khan, R.G. Buick, and J.J. Corkery Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors J Pediatr Surg 31 1996 604 606
9. A. Kurvinen, M.J. Nissinen, S. Andersson, P. Korhonen, T. Ruuska, and M. Taimisto Parenteral plant sterols and intestinal failure-associated liver disease in neonates J Pediatr Gastroenterol Nutr 54 2012 803 811
10. D. García-Galiano, M.A. Sánchez-Garrido, I. Espejo, J.L. Motero, G. Costán, and T. Marchal IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steathepatitis in morbibly obese patients Obes Surg 17 2007 493 503
11. M.S. Mallea-Gil, M.C. Ballarino, A. Spiraquis, M. Iriarte, M. Kura, and S. Gimenez IGF-1 levels in different stages of liver steatosis and its association with metabolic syndrome Acta Gastroenterol Latinoam 42 2012 20 26
12. N. Itoh, and D.M. Ornitz Evolution of the Fgf and Fgfr gene families Trends Genet 20 2004 563 569
13. A. Kharitonenkov, T.L. Shiyanova, A. Koester, A.M. Ford, R. Micanovic, and E.J. Galbreath FGF-21 as a novel metabolic regulator J Clin Invest 115 2005 1627 1635
14. J. Xu, D.J. Lloyd, C. Hale, S. Stanislaus, M. Chen, and G. Sivits Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice Diabetes 58 2009 250 259
15. A. Kharitonenkov, V.J. Wroblewski, A. Koester, Y.F. Chen, C.K. Clutinger, and X.T. Tigno The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21 Endocrinology 148 2007 774 781
16. F.M. Fischer, J.L. Estall, A.C. Adams, P.J. Antonellis, H.A. Bina, and J.S. Flier Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo Endocrinology 152 2011 2996 3004
17. H. Yu, F. Xia, K.S.L. Lam, Y. Wang, Y. Bao, and J. Zhang Circadian rhythm of circulating fibroblast growth factor 21 is related to diurnal changes in fatty acids in humans Clin Chem 57 2011 691 700
18. T. Coscun, H.A. Bina, M.A. Schneider, J.D. Dunbar, C.C. Hu, and Y. Chen FGF21 corrects obesity in mice Endochrinology 149 2008 6018 6027
19. B. Angelin, T.E. Larsson, and M. Rudling Circulating fibroblast growth factors as metabolic regulators -a critical appraisal Cell Metab 16 2012 693 705
20. X. Zhang, D.C. Yeung, M. Karpisek, D. Stejskal, Z.G. Zhou, and F. Liu Serum FGF21 levels are increased in obesity and are independently associated with metabolic syndrome in humans Diabetes 57 2008 1246 1253
21. W.W. Chen, L. Li, G.Y. Yang, K. Li, X.Y. Qi, and W. Zhu Circulating FGF-21 levels in normal subjects and in newly diagnose patients with type 2 diabetes mellitus Exp Clin Endocrinol Diabetes 116 2008 65 68
22. A.O. Chavez, M. Molina-Carrion, M.A. Abdul-Ghani, F. Folli, R.A. Defronzo, and D. Tripathy Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance Diabetes Care 32 2009 1542 1546
23. H. Li, Y. Bao, A. Xu, X. Pan, J. Lu, and H. Wu Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma- glutamyltransferase but not insulin sensitivity in Chinese subjects J Clin Endocrinol Metab 94 2009 2151 2156
24. J. Dushay, P.C. Chui, G.S. Gopalakrishnan, M. Varela-Rey, M. Crawley, and F.M. Fisher Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease Gastroenterology 139 2010 456 463
25. S. Dasarathy, Y. Yang, A.J. McCullough, S. Marczewski, C. Bennett, and S.C. Kalhan Elevated hepatic fatty acid oxidation, high plasma fibroblast growt factor 21, and fasting bile acids in nonalcoholic steatohepatitis Eur J Gastroenterol Hepatol 23 2011 382 388
26. S.C. Fitzgibbons, B.A. Jones, M.A. Hull, D. Zurakowski, D. Duro, and C. Duggan Relationship between biopsy-proven parenteral nutrition-associated liver fibrosis and biochemical cholestasis in children with short bowel syndrome J Pediatr Surg 45 2010 95 99
27. M.P. Pakarinen, A. Kurvinen, A.I. Koivusalo, T. Iber, and R.J. Rintala Long-term controlled outcomes after autologous intestinal reconstruction surgery in treatment of severe short bowel syndrome J Pediatr Surg 48 2013 339 344
28. M.P. Pakarinen, A. Kurvinen, A.I. Koivusalo, T. Ruuska, H. Mäkisalo, and H. Jalanko Surgical treatment and outcomes of severe pediatric intestinal motility disorders requiring parenteral nutrition J Pediatr Surg 48 2013 333 338
29. M.P. Pakarinen, A.I. Koivusalo, and R.J. Rintala Outcomes of intestinal failure - a comparison between children with short bowel syndrome and dysmotile intestine J Pediatr Surg 44 2009 2139 2144
30. M.C. Struijs, I.R. Diamond, N. de Silva, and P.W. Wales Establishing norms for intestinal length in children J Pediatr Surg 44 2009 933 938
31. A. Saari, U. Sankilampi, M.L. Hannila, V. Kiviniemi, K. Kesseli, and L. Dunkel New Finnish growth references for children and adolescents aged 0-20 years: length/height-for-age, weight-for-length/height, and body mass index-for-age Ann Med 43 2011 235 248
32. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man Diabetologia 28 1985 412 419
33. B. Tresaco, G. Bueno, I. Pineda, L.A. Moreno, J.M. Garagorri, and M. Bueno Homeostatic model assessment (HOMA) index cut-off values to identify the metabolic syndrome in children J Physiol Biochem 61 2005 381 388
34. C.T. Wai, J.K. Greenson, R.J. Fontana, J.D. Kalbfleisch, J.A. Marrero, and H.S. Conjeevaram A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 2003 518 526
35. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge Clin Chem 18 1972 499 502
36. P. Bedossa, and T. Poynard An algoritm for the grading of activity in chronic hepatitis C. The METAVIR cooperative study group Hepatology 24 1996 289 293
37. C. Cohen, and M.M. Olsen Pediatric parenteral nutrition. Liver histology Arch Pathol Lab Med 105 1981 152 156
38. B. Peyret, S. Collardeau, S. Touzet, I. Loras-Duclaux, H. Yantren, and M.C. Michalski Prevalence of liver complication in children receiving long-term parenteral nutrition Eur J Clin Nutr 65 2011 743 749
39. P.J. Scheuer, and J.H. Lefcowitch Assessment and differential diagnosis of pathological features 7th ed. P.J. Scheuer, J.H. Lefcowitch, Liver biopsy interpretation vol. 1 2006 Elsevier Saunders Philadelphia, PA 35 51
40. C. Bailly-Botuha, V. Colomb, E. Thioulouse, M.C. Berthe, K. Garcette, and B. Dubern Plasma citrulline concentration reflects enterocyte mass in children with short bowel syndrome Pediatr Res 65 2009 559 563
41. J.S. Stultz, E.M. Tillman, and R.A. Helms Plasma citrulline concentration as a biomarker for bowel loss and adaptation in hospitalized pediatric patients requiring parenteral nutrition Nutr Clin Pract 26 2011 681 687
42. H. Li, Q. Fang, F. Gao, J. Fan, J. Zhou, and X. Wang Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride J Hepatol 53 2010 934 940
43. E. Fassio, E. Alvarez, N. Domínguez, G. Landeira, and C. Longo Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies Hepatology 40 2004 820 826
44. J.H. Lefkowitch, J.H. Haythe, and N. Regent Kuppfer cell aggregation and perivenular distribution in steatohepatitis Mod Pathol 15 2002 699 704
45. P.J. Scheuer, and J.H. Lefcowitch Steatosis and steatohepatitis 7th ed. P.J. Scheuer, J.H. Lefcowitch, Liver biopsy interpretation vol. 1 2006 Elsevier Saunders Philadelphia, PA 105 123
46. P. Arner, A. Petterson, P.J. Mitchell, J.D. Dunbar, A. Kharitonenkov, and M. Ryden FGF21 attenuates lipolysis in human adipocytes - a possible link to improve insulin sensitivity FEBS Lett 582 2008 1725 1730
47. S. Stein, A. Bachmann, U. Lössner, J. Kratzsch, M. Blüher, and M. Stumvoll Serum level of the adipokine FGF21 depend on renal function Diabetes Care 32 2009 126 128
48. Z. Lin, Z. Zhou, Y. Liu, Q. Gong, X. Yan, and J. Xiao Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese PLoS One 6 2011 e18398
49. M.P. Pakarinen, A. Kurvinen, H. Gylling, T.A. Miettinen, M. Pesonen, and M. Kallio Cholesterol metabolism in pediatric short bowel syndrome after weaning off parenteral nutrition Dig Liver Dis 42 2010 554 559
50. A. Kurvinen, M.J. Nissinen, H. Gylling, T.A. Miettinen, H. Lampela, and A.I. Koivusalo Effects of long-term parenteral nutrition on serum lipids, plant sterols, cholesterol metabolism, and liver histology in pediatric intestinal failure J Pediatr Gastroenterol Nutr 53 2011 440 446